Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon 中 contact icon menu icon
Medicilon Logo
|
search icon close search icon 中 contact icon menu icon
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
Over 20 years of experience in R&D
Learn more
01 Drug Discovery
Chemistry Research
Biology Research
Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates
Active Pharmaceutical Ingredients
Pharmaceutical preparation
Analytical Method Development and Quality Control
CMC Filings
Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics
Drug Safety Evaluation
DMPK
Bioanalysis
IND Filings
01 One-stop Integrated Services
Liposome Drug Development
Drug Discovery
Pharmaceutical Research
Preclinical Research
Botanical Drug Preclinical R&D
02 Innovative Drug Services
ADC
PROTAC
mRNA Vaccine
Cellular Immunotherapies
Nucleic Acid Drug
Peptide Drug Conjugate (PDC)
Antibody
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection
Metabolite Identification (MetID)
Drug Forming Research
Flow Cytometry Technology
SEND Format Conversion
Flow Sorting
NanoString nCounter Detection
Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
IO Pharmacodynamic Model
Inflammatory and Immune Diseases
Rodent Cerebrovascular Disease
05 Advanced Preparation R&D
Inhalation drug
Ophthalmic drug
Skin Topical Preparation
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service
GLP-1 New Drug R&D Service
KRAS-targeted Drugs R&D Service
CAREERS
Talent Development
Campus Recruitment
Recruitment
Campus Recruitment
Campus Recruitment
Recruitment
Recruitment
News
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
2024-07-22Medicilon Events
The Shanghai Overseas Returned Scholars Association invites the Dutch PhD delegation to visit Medicilon, exploring paths for innovative development together
On July 4th, the Shanghai Overseas Returned Scholars Association invited the Dutch PhD delegation to visit the Chuansha campus of Shanghai Medicilon Inc. (Medicilon) and held discussions with Medicilon's Founder and CEO, Chunlin Chen, among others.
Learn more
2024-07-22Medicilon Events
5th consecutive win! Medicilon once again made the list of "Top 20 Chinese R&D CRO Enterprises in 2024"
Medicilon stood out among hundreds of pharmaceutical enterprises and was honored with the "Top 20 Chinese R&D CRO Enterprises in 2024" award.
Learn more
INVESTORS
Stock Information
Investment Contact
Medicilon 688202
RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
U.S.

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888|Website Map
关闭
中
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsFeatured Stories

Featured Stories

Hot information：
Top 10 Global CDMO Enterprises| The Meaning of IND, NDA and ANDA| Top 10 Global Clinical Research Organizations in 2021
Mar 12,2018
Alzheimer's Amyloid Gets Immune System Trim
Immune cells in the brain have a trigger, and when it is pulled, it prompts immune cells to degrade toxic β-amyloid (Aβ) proteins. This new finding, from Sanford Burnham Prebys Medical Research Institute (SBP), helps explain why a faulty trigger appears to raise the risk of Alzheimer's disease. Increasing the genetic expression of the triggerRead more
More
Alzheimer's Amyloid Gets Immune System Trim
Mar 09,2018
Glucostat Discovery Has Implications for Diabetes Regenerative Therapies
Researchers in Sweden and the U.S. report new insights into how the human body sets its target blood glucose level – the glycemic set point – and say their findings could have implications for ongoing diabetes research and the development of regenerative therapies.   Every animal species has its own signature glycemic set point, andRead more
More
Mar 09,2018
Diarrheal Disease Protection May Literally Be within Spitting Distance
While it's not typically desirable to think about saliva and diarrhea in the same context, a new study led by investigators at the Boston University School of Medicine (BUSM) may have just uncovered a role for a family of salivary peptides in defending the body against diarrheal disease. The research team identified a protein inRead more
More
Diarrheal Disease Protection May Literally Be within Spitting Distance
Mar 08,2018
Gene-Therapy Trials for Inherited Form of Blindness Could Start in Two Years
Scientists in the U.S. say human trials of gene therapy for an inherited form of blindness known as vitelliform macular degeneration, or Best disease, could be less than two years away, following successful use of the treatment in a canine model of the disease. Developed through a longstanding collaboration between scientists at the University ofRead more
More
Mar 07,2018
Bacteria Resistant to Colistin Present Serious Clinical Challenge
Researchers at Emory Health Sciences have detected “heteroresistance” to colistin, a last-resort antibiotic, in already highly resistant Klebsiella pneumoniae. Their study ("Carbapenem-Resistant Klebsiella pneumoniae Exhibiting Clinically Undetected Colistin Heteroresistance Leads to Treatment Failure in a Murine Model of Infection”) appears in mBio. "Antibiotic resistance is a growing crisis and a grave threat to human health. It isRead more
More
Mar 07,2018
CRISPR Human Knockout Screens Identify New Target for ALS
Through genome editing, a team at Stanford University School of Medicine has used CRISPR/Cas9 technology to gain new insights into the genes that might represent new targets for the neurodegenerative disease amyotrophic lateral sclerosis (ALS) and may even protect against the degeneration of neurons. Led by Aaron Gitler, Ph.D., professor of genetics, and Michael Bassik,Read more
More
CRISPR Human Knockout Screens Identify New Target for ALS
Mar 07,2018
Protein-Protein Interactions Assay
Why PPI (Protein Protein Interaction)? · Protein-Protein Interactions determine the outcome of most cellular processes · Proteins which are close homologues often interact in the same way · Protein-Protein Interactions place evolutionary constraints on protein sequence and structural divergence · Pre-cursor to networks PPI (Protein Protein Interaction) Classification · Strength of interaction — Permanent orRead more
More
Protein-Protein Interactions Assay
Mar 06,2018
Dual Checkpoint Inhibition Boost from New Bifunctional Antibody
Researchers at Johns Hopkins University School of Medicine have developed a new class of bifunctional antibody-based immunotherapy that targets immune checkpoints, but simultaneously disables the production of immunosuppressive regulatory T cells (Tregs). The new molecules, dubbed Y-traps, comprise a Y-shaped antibody fused to a transforming growth factor beta (TGF-β) receptor domain that switches off theRead more
More
Dual Checkpoint Inhibition Boost from New Bifunctional Antibody
Mar 06,2018
Heart Tissue Regeneration through Cell Cycle Tweaks
Researchers at the Gladstone Institutes say they have developed an efficient and stable method to make adult cardiomyocytes divide and repair hearts damaged by heart attacks. They published their study ("Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration”) in Cell. "Human diseases are often caused by loss of somatic cells that areRead more
More
Heart Tissue Regeneration through Cell Cycle Tweaks
Mar 06,2018
What is Preclinical ADME Studies?
ADME studies–ADME is an abbreviation in pharmacokinetics and pharmacology, stands for absorption, distribution, metabolism and elimination of chemicals and drugs to define the impact in a human body. Toxicology testing is a significant event before an introduction of new drugs into the market. However, drug development is a very crucial stage of the pharmaceutical andRead more
More
What is Preclinical ADME Studies?
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->